EXTEND-IA TNK

Project Details

A clinical trial comparing two different clot-dissolving medications in ischemic stroke patients planned for endovascular stroke treatment. EXTEND-IA TNK randomizes patients to alteplase 0.9mg/kg versus tenecteplase 0.25mg/kg The primary outcome is the rate of reperfusion prior to endovascular treatment.

https://www.clinicaltrials.gov/ct2/show/NCT02388061

Funding

  • NHMRC
  • Heart Foundation

Research Group

Stroke Imaging and Treatment



Faculty Research Themes

Neuroscience

School Research Themes

Neuroscience & Psychiatry



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Medicine and Radiology